ICAM1 and neoplasm: In vitro, DOX@E-PSiNPs can induce low expression of multidrug-resistant protein P-glycoprotein (P-gp), resulting in decreased cell membrane fluidity, which enhances intracellular retention, and its targeting ability to tumor cells is regulated by CD54 (ICAM1), making these exhibit strong cellular uptake.